Stay updated on Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page.

Latest updates to the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page
- Check4 days agoChange DetectedA new record version (67) with Revision: v3.5.5 was added, updating core sections such as Study Status, Contacts/Locations, and Arms and Interventions. The previous revision (v3.5.4) was removed from the history.SummaryDifference0.3%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page footer now displays Revision: v3.5.4, replacing the previous v3.5.3. This indicates a deployment of a new build for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check32 days agoChange DetectedNew history entries add Contacts/Locations, Eligibility, and Study Status to the record, reflecting updates to how the study's sites, eligibility criteria, and current status are tracked. The changes appear in the version history around 2026-04-28 and 2026-05-04, with a deletion noted on 2026-02-23.SummaryDifference0.3%

- Check47 days agoChange DetectedClinicalTrials.gov’s page footer now shows the updated site revision number (from v3.5.2 to v3.5.3), indicating a platform/version update rather than a modification to the study record itself.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inotuzumab for Young Patients with B-Lymphoblastic Lymphoma Clinical Trial page.